Navigation Links
Plastic Surgeon Allan Parungao, MD, FACS, Announces Clinical Trial of Juvderm Technique to Treat Root Cause of Midface Sagging, without Surgery
Date:3/27/2009

An experience trial at the Hinsdale Center for Plastic Surgery in suburban Chicago will study the effects of the new Juvéderm Midface Rejuvenation, or JuMiR, technique designed to instantly treat a key cause of facial aging.

Hinsdale, Ill. (PRWEB) March 27, 2009 -- The Hinsdale Center for Plastic Surgery and its Skin Elegance Medical Spa are conducting an experience trial to study the effects of a new non-surgical facial rejuvenation technique.

"The Juvéderm Midface Rejuvenation, or JuMiR, technique focuses on treating the underlying cause of deepening nasolabial folds from the nose to the corners of the mouth: a sagging midface," explains Allan Parungao, MD, FACS.

Juvéderm, from Allergan, Inc., is an injectable facial filler made of hyaluronic acid, a naturally occurring substance in the skin that helps add volume and restore moisture.

"Facial fillers such as Juvéderm are typically injected directly into the nasolabial folds, or NLFs, which tend to deepen as we age," says Dr. Parungao, author of A Woman's Guide to Cosmetic Breast Surgery and Body Contouring.

"That treatment technique 'chases' the NLF groove by filling it with Juvéderm," explains Skin Elegance Medical Spa Director Maria Maloto, RN. "But the JuMiR technique, developed by California nurse-injector Leslie Fletcher, RN, involves injecting Juvéderm in strategic locations above the NLFs.

"Rather than correcting the fold itself, the JuMiR technique corrects the loss of midface volume that causes deepening NLFs," says Maloto. "Essentially, JuMiR uses Juvéderm to restore the support beams of the midface."

JuMiR experience trial participants include women ages 40 to 65 who have had a traditional Juvéderm treatment at least three months before the study for moderate to severe NLFs.

"Study participants will report on the differences they perceive in the results of injections directly into the NLFs vs. the JuMiR technique," says Dr. Parungao. "Clinical observations and before-and-after photos will also be used to compare the results of the two techniques."

The trial will study many aspects of the JuMiR technique, such as how soon the effects are noticeable, how natural the face looks after treatment, the incidence of swelling and bruising, and how the long the treatment effects last.

Already, the JuMiR technique has a proven benefit: it requires less Juvéderm than injecting directly into the NLFs. "This translates into more value for our patients," says Dr. Parungao.

"Juvéderm treatments are priced per syringe," Maloto explains. "Having product left over after treating the NLFs allows us to treat other areas of the face, such as 'marionette lines' from the corners of the mouth to the chin, at no extra cost. Our patients really appreciate that."

Chris, a 51-year-old baby boomer who has had traditional NLF Juvéderm injections, recently tried a JuMiR treatment for the first time. "The JuMiR treatment made my face feel filled out," she says. "It plumped up my cheeks and got rid of that 'sunken' look. And I noticed that the JuMiR treatment actually turned up the corners of my mouth."

Another difference from the traditional NLF injections: "I had absolutely no bruising with the JuMiR technique, and normally I do bruise," says Chris.

Injectable facial treatments such as Juvéderm and Botox have become increasingly popular. "Many women and men are looking for ways to make their face look younger--without the expense or downtime of plastic surgery," Dr. Parungao explains.

Just-released statistics from the American Society for Aesthetic Plastic Surgery show that 83% of the more than 10 million cosmetic procedures performed in 2008 were non-surgical. Americans had 1,262,848 hyaluronic acid filler procedures in 2008 alone.

"Especially these days, people are looking for affordable ways to look their best," says Dr. Parungao. "Lunchtime injectable treatments like Juvéderm are only a fraction of the cost of surgical procedures--with no downtime."

For more information on Juvéderm, visit www.parungao.com/facial-enhancements/juvederm. To schedule a JuMiR treatment, call the Hinsdale Center for Plastic Surgery at 630.794.0700.

Allan Parungao, MD, FACS, is a Hinsdale, Ill. plastic surgeon and author board-certified by the American Board of Plastic Surgery, with offices in Hinsdale and Naperville, Ill. For more information, visit www.parungao.com.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2269434.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Water Picks Up Odor From Plastic Pipes
2. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
3. The Current Recall of Boy Scouts of Americas Plastic Badges Does Not Affect Embroidered Insignia, Badges & Awards Produced by Lion Brothers Company Inc.
4. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
5. Body Image Has Little Influence on Desire for Plastic Surgery, ASPS Study Reveals
6. New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming
7. New York City Aesthetic Plastic Surgeon Welcomes top Skin Care Line into his Office
8. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
9. Plastic Surgery Complications and Deaths are Rare, Despite Highly Publicized Death of Donda West
10. Guide to Minimizing Your Plastic Surgery Risks
11. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plastic Surgeon Allan Parungao, MD, FACS, Announces Clinical Trial of Juvderm Technique to Treat Root Cause of Midface Sagging, without Surgery
(Date:2/12/2016)... ... ... The law firm of Morrow, Morrow, Ryan & Bassett is offering scholarships to ... to encourage applicants to pursue a degree in their field of study and upon ... “We have available jobs in St. Landry and Evangeline Parishes that can be filled ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, ... ... in Store?, Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, ... burner issue in the life cycle of pharmaceutical products, garnering increased attention from ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Fisher House Foundation ... Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns ... the VA Southern Nevada Healthcare System. This will be the first Fisher House ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Erlanger Agency ... the greater Columbus, OH area. The latest campaign focuses on the fight against breast ... Donations are now being accepted here . , Carmen is a loving single ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... Feb. 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ... the Company will ring the Nasdaq Closing Bell at ... York at 4:00 p.m. ET on Tuesday, ... Adrian Adams , will perform the ... to 4:00 p.m. ET.  A live webcast will be ...
(Date:2/12/2016)... 2016 --> ... Inflammation Global Clinical Trials Review, H2, 2015 provides ... clinical trials landscape along with top level data ... (G7 & E7), Trial Status, Trial Phase, Sponsor ... companies involved and enlists all trials (Trial title, ...
Breaking Medicine Technology: